Published in J Clin Sleep Med on August 15, 2015
Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res (2016) 0.80
Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis. Braz J Med Biol Res (2017) 0.75
Consider the Kidney when Managing Obstructive Sleep Apnea. J Clin Sleep Med (2015) 0.75
Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome. Pulm Med (2016) 0.75
Commentary: Stress Signal Network between Hypoxia and ER Stress in Chronic Kidney Disease. Front Physiol (2017) 0.75
Impact of Compression Stockings vs. Continuous Positive Airway Pressure on Overnight Fluid Shift and Obstructive Sleep Apnea among Patients on Hemodialysis. Front Med (Lausanne) (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93
Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med (2000) 18.12
Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26
Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16
Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol (2013) 7.31
Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest (1995) 6.64
The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc (2008) 6.33
Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 5.66
Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol (2005) 4.35
Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes (2008) 4.13
Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med (1995) 3.15
The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int (1996) 2.97
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens (2001) 2.95
Upper airway sensation in snoring and obstructive sleep apnea. Am J Respir Crit Care Med (2001) 2.93
Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis (1993) 2.61
Central sleep apnea: Pathophysiology and treatment. Chest (2007) 2.59
Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med (2001) 2.49
Anatomy of pharynx in patients with obstructive sleep apnea and in normal subjects. J Appl Physiol (1985) (1997) 2.44
Computerized tomography in obstructive sleep apnea. Correlation of airway size with physiology during sleep and wakefulness. Am Rev Respir Dis (1983) 2.18
Sleep apnea and heart failure: Part I: obstructive sleep apnea. Circulation (2003) 2.06
Chemoreflexes--physiology and clinical implications. Acta Physiol Scand (2003) 2.03
High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol (2011) 1.98
Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med (2008) 1.94
Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med (1999) 1.92
What is oxidative stress? Metabolism (2000) 1.87
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ (2013) 1.81
Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol (2012) 1.80
Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2008) 1.80
Evaluation of continuous positive airway pressure therapy on renin-angiotensin system activity in obstructive sleep apnea. Am J Respir Crit Care Med (2014) 1.74
Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest (2012) 1.73
Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med (2008) 1.72
Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation (1999) 1.65
Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrol Dial Transplant (2011) 1.58
Role of hypoxia in the pathogenesis of renal disease. Kidney Int Suppl (2005) 1.57
Insights into obstructive sleep apnea research. Sleep Med (2014) 1.49
Resistant hypertension and obstructive sleep apnea in the setting of kidney disease. J Hypertens (2012) 1.49
Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest (2006) 1.47
Prevalence of obstructive sleep apnea syndrome in a cohort of 1,207 children of southern Italy. Chest (2001) 1.47
Obstructive sleep apnea in adults: epidemiology, clinical presentation, and treatment options. Adv Cardiol (2011) 1.42
Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.42
Obesity, sleep apnea, and hypertension. Hypertension (2003) 1.41
A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol (1985) (2001) 1.40
Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment. Kidney Int (2004) 1.40
Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest (2007) 1.38
Prevalence of symptoms and risk of sleep apnea in middle-aged Saudi males in primary care. Saudi Med J (2008) 1.32
Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects. Am J Respir Crit Care Med (2006) 1.29
The ventilatory responsiveness to CO(2) below eupnoea as a determinant of ventilatory stability in sleep. J Physiol (2004) 1.29
Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung (2006) 1.22
Obesity in arabic-speaking countries. J Obes (2011) 1.22
Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med (2014) 1.20
The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens (1997) 1.20
Sleep apnea syndrome in chronic renal disease. Am J Med (1989) 1.20
Factors regulating isoprostane formation in vivo. Antioxid Redox Signal (2005) 1.18
Prevalence of sleep apnea-related symptoms in a Persian population. Sleep Breath (2010) 1.17
Prevalence of symptoms and risk of sleep apnea in middle-aged Saudi women in primary care. Saudi Med J (2009) 1.14
Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension (2000) 1.11
The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant (2007) 1.10
Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'? Kidney Int (2006) 1.10
Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) (2004) 1.09
Sleep disorders over the full range of chronic kidney disease. Blood Purif (2011) 1.09
Oxidative stress in chronic renal failure. Nephrol Dial Transplant (2001) 1.08
[Prevalence of symptoms of sleep apnea syndrome. Study of a French middle-aged population]. Rev Mal Respir (2007) 1.08
Enhanced chemo-responsiveness in patients with sleep apnoea and end-stage renal disease. Eur Respir J (2006) 1.08
Nocturnal hypoxia and loss of kidney function. PLoS One (2011) 1.07
Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol (1985) (2004) 1.05
Causes and consequences of chronic kidney disease: implications for managed health care. J Manag Care Pharm (2007) 1.04
Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration (2011) 1.02
Clinical and research markers of oxidative stress in chronic kidney disease. Biomarkers (2013) 1.00
Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis (2012) 1.00
Interactions between the sympathetic nervous system and the kidneys in arterial hypertension. Cardiovasc Res (2004) 1.00
Effect of episodic hypoxia on the susceptibility to hypocapnic central apnea during NREM sleep. J Appl Physiol (1985) (2009) 1.00
Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial (2004) 0.99
High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res (2008) 0.99
Oxidative stress in obstructive sleep apnea: putative pathways to the cardiovascular complications. Antioxid Redox Signal (2008) 0.99
Renal tubulointerstitial hypoxia: cause and consequence of kidney dysfunction. Clin Exp Pharmacol Physiol (2011) 0.99
Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children. Front Neurol (2012) 0.99
Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant (2007) 0.99
Impact of sleep apnea on sympathetic nervous system activity in heart failure. Chest (2003) 0.99
Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol (2008) 0.98
Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnoea. Eur Respir J (2007) 0.98
Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant (2009) 0.96
Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives. Pharmacol Ther (2010) 0.95
Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Nephron Exp Nephrol (2004) 0.95
Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst (2010) 0.95
Upperairway myopathy is important in the pathophysiology of obstructive sleep apnea. J Clin Sleep Med (2007) 0.94
Obstructive sleep apnea: an update on mechanisms and cardiovascular consequences. Nutr Metab Cardiovasc Dis (2007) 0.94
Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res (2014) 0.94
Role of acid-base balance in the chemoreflex control of breathing. J Appl Physiol (1985) (2005) 0.93
Sleep apnea in renal patients. J Am Soc Nephrol (2001) 0.92
The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep (2010) 0.92
Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediators Inflamm (2012) 0.92
Factors that render the kidney susceptible to tissue hypoxia in hypoxemia. Am J Physiol Regul Integr Comp Physiol (2011) 0.91
Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med (2011) 0.90
The relationship of daytime hypoxemia and nocturnal hypoxia in obstructive sleep apnea syndrome. Sleep (2008) 0.90
The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. Eur J Pharmacol (2010) 0.89
Sleep apnea in renal failure. Adv Perit Dial (1997) 0.89